1
|
Reddy MLP, Bejoymohandas KS. Luminescent lanthanide-based molecular materials: applications in photodynamic therapy. Dalton Trans 2024; 53:1898-1914. [PMID: 38189418 DOI: 10.1039/d3dt04064j] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2024]
Abstract
Luminescent lanthanide molecular compounds have recently attracted attention as potential photosensitizers (PSs) for photodynamic therapy (PDT) against malignant cancer tumours because of their predictable systemic toxicity, temporospatial specificity, and minimal invasiveness. A photosensitizer exhibits no toxicity by itself, but in the presence of light and oxygen molecules, it can generate reactive oxygen species (ROS) to cause damage to proteins, nucleic acids, lipids, membranes, and organelles, which can induce cell apoptosis. This review focuses on the latest developments in luminescent lanthanide-based molecular materials as photosensitizers and their applications in photodynamic therapy. These molecular materials include lanthanide coordination complexes, nanoscale lanthanide coordination polymers, and lanthanide-based nanoscale metal-organic frameworks. In the end, the future challenges in the development of robust luminescent lanthanide molecular materials-based photosensitisers are outlined and emphasized to inspire the design of a new generation of phototheranostic agents.
Collapse
Affiliation(s)
- M L P Reddy
- CSIR-National Institute for Interdisciplinary Science & Technology (CSIR-NIIST), Thiruvananthapuram, 695 019, India.
| | - K S Bejoymohandas
- Istituto per la Sintesi Organica e la Fotoreattività, Consiglio Nazionale delle Ricerche (ISOF-CNR), Via Piero Gobetti 101, 40129 Bologna, Italy
| |
Collapse
|
2
|
Boumati S, Sour A, Heitz V, Seguin J, Beitz G, Kaga Y, Jakubaszek M, Karges J, Gasser G, Mignet N, Doan BT. Three in One: In Vitro and In Vivo Evaluation of Anticancer Activity of a Theranostic Agent that Combines Magnetic Resonance Imaging, Optical Bioimaging, and Photodynamic Therapy Capabilities. ACS APPLIED BIO MATERIALS 2023; 6:4791-4804. [PMID: 37862269 DOI: 10.1021/acsabm.3c00565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2023]
Abstract
Cancer treatment is a crucial area of research and development, as current chemotherapeutic treatments can have severe side effects or poor outcomes. In the constant search for new strategies that are localized and minimally invasive and produce minimal side effects, photodynamic therapy (PDT) is an exciting therapeutic modality that has been gaining attention. The use of theranostics, which combine diagnostic and therapeutic capabilities, can further improve treatment monitoring through image guidance. This study explores the potential of a theranostic agent consisting of four Gd(III) DTTA complexes (DTTA: diethylenetriamine-N,N,N″,N″-tetraacetate) grafted to a meso-tetraphenylporphyrin core for PDT, fluorescence, and magnetic resonance imaging (MRI). The agent was first tested in vitro on both nonmalignant TIB-75 and MRC-5 and tumoral CT26 and HT-29 cell lines and subsequently evaluated in vivo in a preclinical colorectal tumor model. Advanced MRI and optical imaging techniques were employed with engineered quantitative in vivo molecular imaging based on dynamic acquisition sequences to track the biodistribution of agents in the body. With 3D quantitative volume computed by MRI and tumoral cell function assessed by bioluminescence imaging, we could demonstrate a significant impact of the molecular agent on tumor growth following light application. Further exhaustive histological analysis confirmed these promising results, making this theranostic agent a potential drug candidate for cancer.
Collapse
Affiliation(s)
- Sarah Boumati
- Université PSL Chimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences (I-CLeHS), SEISAD, 75005 Paris, France
| | - Angélique Sour
- Université de Strasbourg, Institut de Chimie de Strasbourg, CNRS, UMR 7177, Laboratoire LSAMM, 67070 Strasbourg, France
| | - Valérie Heitz
- Université de Strasbourg, Institut de Chimie de Strasbourg, CNRS, UMR 7177, Laboratoire LSAMM, 67070 Strasbourg, France
| | - Johanne Seguin
- Université Paris Cité, CNRS, Inserm, Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), 75006 Paris, France
| | - Gautier Beitz
- Université PSL Chimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences (I-CLeHS), SEISAD, 75005 Paris, France
| | - Yusuke Kaga
- Université PSL Chimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences (I-CLeHS), SEISAD, 75005 Paris, France
| | - Marta Jakubaszek
- Université PSL, Chimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences (I-CLeHS), Laboratory for Inorganic Chemical Biology, 75005 Paris, France
| | - Johannes Karges
- Université PSL, Chimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences (I-CLeHS), Laboratory for Inorganic Chemical Biology, 75005 Paris, France
| | - Gilles Gasser
- Université PSL, Chimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences (I-CLeHS), Laboratory for Inorganic Chemical Biology, 75005 Paris, France
| | - Nathalie Mignet
- Université Paris Cité, CNRS, Inserm, Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), 75006 Paris, France
| | - Bich-Thuy Doan
- Université PSL Chimie ParisTech, CNRS, Institute of Chemistry for Life and Health Sciences (I-CLeHS), SEISAD, 75005 Paris, France
| |
Collapse
|
3
|
Shilyagina NY, Shestakova LN, Peskova NN, Lermontova SA, Lyubova TS, Klapshina LG, Balalaeva IV. Cyanoarylporphyrazine dyes: multimodal compounds for personalised photodynamic therapy. Biophys Rev 2023; 15:971-982. [PMID: 37975009 PMCID: PMC10643710 DOI: 10.1007/s12551-023-01134-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Accepted: 08/30/2023] [Indexed: 11/19/2023] Open
Abstract
Photodynamic therapy is known as an effective primary and adjuvant anticancer treatment. Compounds with improved properties or additional modalities are still needed to create an 'ideal' photosensitizer. In this article, we review cyanoarylporphyrazine dyes for photodynamic (anticancer) therapy that we have synthesised to date. The review provides information on the chemistry of cyanoarylporphyrazines, photophysical properties, cellular uptake features and the use of various carriers for selective delivery of cyanoarylporphyrazines to the tumour. The potential of cyanoarylporphyrazines as photodynamic anti-tumour agents also has been evaluated. The most interesting feature of cyanoarylporphyrazines is the dependence of the fluorescence quantum yield and excited state lifetime on the viscosity of the medium, which makes it possible to use them as viscosity sensors in photodynamic therapy. In the future, we expect that the unique combination of photosensitizer and viscosity sensor properties of cyanoarylporphyrazines will provide a tool for dosimetry and tailoring treatment regimens in photodynamic therapy to the individual characteristics of each patient.
Collapse
Affiliation(s)
- N Yu Shilyagina
- Institute of Biology and Biomedicine, Lobachevsky State University, Gagarin Ave., 23, 603022 Nizhny Novgorod, Russia
| | - L N Shestakova
- Institute of Biology and Biomedicine, Lobachevsky State University, Gagarin Ave., 23, 603022 Nizhny Novgorod, Russia
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinin str., 49, 603137 Nizhny Novgorod, Russia
| | - N N Peskova
- Institute of Biology and Biomedicine, Lobachevsky State University, Gagarin Ave., 23, 603022 Nizhny Novgorod, Russia
| | - S A Lermontova
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinin str., 49, 603137 Nizhny Novgorod, Russia
| | - T S Lyubova
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinin str., 49, 603137 Nizhny Novgorod, Russia
| | - L G Klapshina
- Razuvaev Institute of Organometallic Chemistry, Russian Academy of Sciences, Tropinin str., 49, 603137 Nizhny Novgorod, Russia
| | - I V Balalaeva
- Institute of Biology and Biomedicine, Lobachevsky State University, Gagarin Ave., 23, 603022 Nizhny Novgorod, Russia
| |
Collapse
|
4
|
Lima E, Reis LV. Photodynamic Therapy: From the Basics to the Current Progress of N-Heterocyclic-Bearing Dyes as Effective Photosensitizers. Molecules 2023; 28:5092. [PMID: 37446758 DOI: 10.3390/molecules28135092] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2023] [Revised: 06/16/2023] [Accepted: 06/27/2023] [Indexed: 07/15/2023] Open
Abstract
Photodynamic therapy, an alternative that has gained weight and popularity compared to current conventional therapies in the treatment of cancer, is a minimally invasive therapeutic strategy that generally results from the simultaneous action of three factors: a molecule with high sensitivity to light, the photosensitizer, molecular oxygen in the triplet state, and light energy. There is much to be said about each of these three elements; however, the efficacy of the photosensitizer is the most determining factor for the success of this therapeutic modality. Porphyrins, chlorins, phthalocyanines, boron-dipyrromethenes, and cyanines are some of the N-heterocycle-bearing dyes' classes with high biological promise. In this review, a concise approach is taken to these and other families of potential photosensitizers and the molecular modifications that have recently appeared in the literature within the scope of their photodynamic application, as well as how these compounds and their formulations may eventually overcome the deficiencies of the molecules currently clinically used and revolutionize the therapies to eradicate or delay the growth of tumor cells.
Collapse
Affiliation(s)
- Eurico Lima
- CQ-VR-Chemistry Centre of Vila Real, University of Trás-os-Montes and Alto Douro, Quinta de Prados, 5001-801 Vila Real, Portugal
- CICS-UBI-Health Sciences Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6201-506 Covilhã, Portugal
| | - Lucinda V Reis
- CQ-VR-Chemistry Centre of Vila Real, University of Trás-os-Montes and Alto Douro, Quinta de Prados, 5001-801 Vila Real, Portugal
| |
Collapse
|
5
|
Nemeth T, Yoshizawa-Sugata N, Pallier A, Tajima Y, Ma Y, Tóth É, Masai H, Yamakoshi Y. Water-Soluble Gd(III)-Porphyrin Complexes Capable of Both Photosensitization and Relaxation Enhancement. CHEMICAL & BIOMEDICAL IMAGING 2023; 1:157-167. [PMID: 37235189 PMCID: PMC10207321 DOI: 10.1021/cbmi.3c00007] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Revised: 04/26/2023] [Accepted: 04/28/2023] [Indexed: 05/28/2023]
Abstract
With the aim of developing more stable Gd(III)-porphyrin complexes, two types of ligands 1 and 2 with carboxylic acid anchors were synthesized. Due to the N-substituted pyridyl cation attached to the porphyrin core, these porphyrin ligands were highly water-soluble and formed the corresponding Gd(III) chelates, Gd-1 and Gd-2. Gd-1 was sufficiently stable in neutral buffer, presumably due to the preferred conformation of the carboxylate-terminated anchors connected to nitrogen in the meta position of the pyridyl group helping to stabilize Gd(III) complexation by the porphyrin center. 1H NMRD (nuclear magnetic relaxation dispersion) measurements on Gd-1 revealed high longitudinal water proton relaxivity (r1 = 21.2 mM-1 s-1 at 60 MHz and 25 °C), which originates from slow rotational motion resulting from aggregation in aqueous solution. Under visible light irradiation, Gd-1 showed extensive photoinduced DNA cleavage in line with efficient photoinduced singlet oxygen generation. Cell-based assays revealed no significant dark cytotoxicity of Gd-1, while it showed sufficient photocytotoxicity on cancer cell lines under visible light irradiation. These results indicate the potential of this Gd(III)-porphyrin complex (Gd-1) as a core for the development of bifunctional systems acting as an efficient photodynamic therapy photosensitizer (PDT-PS) with magnetic resonance imaging (MRI) detection capabilities.
Collapse
Affiliation(s)
- Tamas Nemeth
- Department
of Chemistry and Applied Biosciences, ETH
Zürich, Vladimir-Prelog-Weg 3, CH8093 Zürich, Switzerland
| | - Naoko Yoshizawa-Sugata
- Research
Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya, Tokyo 156-8506, Japan
| | - Agnes Pallier
- Centre
de Biophysique Moléculaire, CNRS UPR 4301, University of Orléans, Rue Charles Sadron, 45071 Cedex 2 Orléans, France
| | - Youichi Tajima
- Department
of Basic Medical Sciences, Tokyo Metropolitan
Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya, Tokyo 156-8506, Japan
| | - Yue Ma
- Department
of Chemistry and Applied Biosciences, ETH
Zürich, Vladimir-Prelog-Weg 3, CH8093 Zürich, Switzerland
| | - Éva Tóth
- Centre
de Biophysique Moléculaire, CNRS UPR 4301, University of Orléans, Rue Charles Sadron, 45071 Cedex 2 Orléans, France
| | - Hisao Masai
- Department
of Basic Medical Sciences, Tokyo Metropolitan
Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya, Tokyo 156-8506, Japan
| | - Yoko Yamakoshi
- Department
of Chemistry and Applied Biosciences, ETH
Zürich, Vladimir-Prelog-Weg 3, CH8093 Zürich, Switzerland
| |
Collapse
|
6
|
Lermontova SA, Arsenyev MV, Cherkasov AV, Fukin GK, Afanasyev AV, Yudintsev AV, Grigoryev IS, Ladilina EY, Lyubova TS, Shilyagina NY, Balalaeva IV, Klapshina LG, Piskunov AV. Novel Rigidochromic and Anti-Kasha Dual Emission Fluorophores Based on D-π-A Dyads as the Promising Materials for Potential Applications Ranging from Optoelectronics and Optical Sensing to Biophotonics and Medicine. Int J Mol Sci 2023; 24:ijms24065818. [PMID: 36982890 PMCID: PMC10057995 DOI: 10.3390/ijms24065818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2022] [Revised: 03/10/2023] [Accepted: 03/14/2023] [Indexed: 03/30/2023] Open
Abstract
Today we see an increasing demand for new fluorescent materials exhibiting various sensory abilities due to their broad applicability ranging from the construction of flexible devices to bioimaging. In this paper, we report on the new fluorescent pigments AntTCNE, PyrTCNE, and PerTCNE which consist of 3-5 fused aromatic rings substituted with tricyanoethylene fragments forming D-π-A diad. Our studies reveal that all three compounds exhibit pronounced rigidochromic properties, i.e., strong sensitivity of their fluorescence to the viscosity of the local environment. We also demonstrate that our new pigments belong to a very rare type of organic fluorophores which do not obey the well-known empirical Kasha'rule stating that photoluminescence transition always occurs from the lowest excited state of an emitting molecule. This rare spectral feature of our pigments is accompanied by an even rarer capability of spectrally and temporally well-resolved anti-Kasha dual emission (DE) from both higher and lowest electronic states in non-polar solvents. We show that among three new pigments, PerTCNE has significant potential as the medium-bandgap non-fullerene electron acceptor. Such materials are now highly demanded for indoor low-power electronics and portable devices for the Internet-of-Things. Additionally, we demonstrate that PyrTCNE has been successfully used as a structural unit in template assembling of the new cyanoarylporphyrazine framework with 4 D-π-A dyads framing this macrocycle (Pyr4CN4Pz). Similarly to its structural unit, Pyr4CN4Pz is also the anti-Kasha fluorophore, exhibiting intensive DE in viscous non-polar medium and polymer films, which strongly depends on the polarity of the local environment. Moreover, our studies showed high photodynamic activity of this new tetrapyrrole macrocycle which is combined with its unique sensory capacities (strong sensitivity of its fluorescent properties to the local environmental stimuli such as viscosity and polarity. Thus, Pyr4CN4Pz can be considered the first unique photosensitizer that potentially enables the real-time combination of photodynamic therapy and double-sensory approaches which is very important for modern biomedicine.
Collapse
Affiliation(s)
- Svetlana A Lermontova
- G.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia
| | - Maxim V Arsenyev
- G.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia
| | - Anton V Cherkasov
- G.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia
| | - Georgy K Fukin
- G.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia
| | | | - Andrey V Yudintsev
- Biological Faculty, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia
| | - Ilya S Grigoryev
- G.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia
| | - Elena Yu Ladilina
- G.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia
| | - Tatyana S Lyubova
- G.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia
| | - Natalia Yu Shilyagina
- Biological Faculty, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia
| | - Irina V Balalaeva
- Biological Faculty, Lobachevsky State University of Nizhny Novgorod, 603950 Nizhny Novgorod, Russia
| | - Larisa G Klapshina
- G.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia
| | - Alexandr V Piskunov
- G.A. Razuvaev Institute of Organometallic Chemistry of RAS, 603950 Nizhny Novgorod, Russia
| |
Collapse
|
7
|
Jin GQ, Lai H, Yang ZS, Ning Y, Duan L, Zhang J, Chen T, Gao S, Zhang JL. Gadolinium(III) Porphyrinoid Phototheranostics. Chem Asian J 2022; 17:e202200181. [PMID: 35343080 DOI: 10.1002/asia.202200181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Revised: 03/21/2022] [Indexed: 11/08/2022]
Abstract
Molecular phototheranostics as the emerging field of modern precision medicine recently has attracts increasing research attentions owing to non-invasiveness, high precision, and controllable nature of light. In this work, we reported alluring gadolinium (Gd3+) porphyrinoids phototheranostic agents for magnetic resonance imaging (MRI) and photodynamic therapy (PDT). The synthesized Gd-1-4-Glu featured with meso-glycosylation and β-lactonization to endow good biocompatibility and improved photophysical properties. In particular, β-lactonization of glycosylated Gd3+ porphyrinoids substantially red-shifted its absorption band to near-infrared (NIR) region and boosted generation of reactive oxygen species including 1O2, and some radical species that engaged both type II and type I PDT pathways. In addition, the number and regioisomerism of β-oxazolone moieties was observed to play an essential role in improving longitude relaxivity (r1) of Gd-1-4-Glu up to 4.6 mM-1s-1 for the first time by affecting environmental water exchange. Taking Gd-4-Glu as a promising complex, we further achieved real-time T1-weighted MRI and PDT on HeLa tumour mice in vivo, revealing the appealing potential of Gd3+ porphyrinoids in phototheranostics.
Collapse
Affiliation(s)
- Guo-Qing Jin
- Peking University, College of Chemistry and Molecular Engineering, Beijing, 10087, Beijing, CHINA
| | - Haoqiang Lai
- Jinan University, Department of Chemistry, CHINA
| | - Zi-Shu Yang
- Peking University, College of Chemistry and Molecular Engineering, CHINA
| | - Yingying Ning
- Peking University, College of Chemistry and Molecular Engineering, CHINA
| | - Linqi Duan
- Jinan University, Department of Chemistry, CHINA
| | - Jing Zhang
- University of the Chinese Academy of Sciences, , CHINA
| | | | - Song Gao
- Peking University, College of Chemistry and Molecular Engineering, CHINA
| | - Jun-Long Zhang
- Peking University, College of Chemistry and Molecular Engineering, Chengfu Road 202, 100871, Beijing, CHINA
| |
Collapse
|
8
|
Kim S, Yang JU, Ahn JH, Ko IO, Kim JY, Lee YJ, Park JA. Porphyrin-Based Tumor-Targeting Theranostic Agent: Gd-TDAP. ACS Med Chem Lett 2021; 12:1459-1463. [PMID: 34531954 PMCID: PMC8436409 DOI: 10.1021/acsmedchemlett.1c00283] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2021] [Accepted: 08/11/2021] [Indexed: 12/11/2022] Open
Abstract
The aim of this work was to evaluate a tumor-targeting porphyrin-based gadolinium complex (Gd-TDAP) for use as an MR/optical imaging agent and potential therapeutic agent. Gd-TDAP had higher longitudinal relaxivity (11.8 mM-1 s-1) than a commercial MRI contrast agent (Omniscan; 3.7 mM-1 s-1) in HSA solution (0.67 mM) at 3 T. The tumor-targeting characteristics were confirmed by T1-weighted MR imaging and optical imaging using an orthotopic brain tumor mouse model, which showed 1.3-fold higher uptake in tumor compared to normal brain tissues. The cell fraction data using U87MG glioblastoma cells indicated the potential for gadolinium neutron capture therapy (Gd-NCT), which requires gadolinium to be inside the cell nucleus. In addition, porphyrin derivatives can be used for photodynamic therapy (PDT), and the results demonstrated that Gd-TDAP has great potential not only as a bimodal imaging agent but also for treatment.
Collapse
Affiliation(s)
- Soyeon Kim
- Division
of Applied RI, Korea Institute of Radiological
& Medical Sciences (KIRAMS), Seoul 01812, Korea
- Department
of Medical & Biological Engineering, Kyungpook National University, Daegu 41566, Korea
| | - Ji-ung Yang
- Division
of Applied RI, Korea Institute of Radiological
& Medical Sciences (KIRAMS), Seoul 01812, Korea
- Department
of Medical & Biological Engineering, Kyungpook National University, Daegu 41566, Korea
| | - Jae Hun Ahn
- Division
of Applied RI, Korea Institute of Radiological
& Medical Sciences (KIRAMS), Seoul 01812, Korea
- Graduate
School of Translational Medicine, Seoul
National University College of Medicine, Seoul 03080, Korea
| | - In Ok Ko
- Division
of Applied RI, Korea Institute of Radiological
& Medical Sciences (KIRAMS), Seoul 01812, Korea
| | - Jung Young Kim
- Division
of Applied RI, Korea Institute of Radiological
& Medical Sciences (KIRAMS), Seoul 01812, Korea
| | - Yong Jin Lee
- Division
of Applied RI, Korea Institute of Radiological
& Medical Sciences (KIRAMS), Seoul 01812, Korea
| | - Ji-Ae Park
- Division
of Applied RI, Korea Institute of Radiological
& Medical Sciences (KIRAMS), Seoul 01812, Korea
| |
Collapse
|
9
|
Sarbadhikary P, George BP, Abrahamse H. Recent Advances in Photosensitizers as Multifunctional Theranostic Agents for Imaging-Guided Photodynamic Therapy of Cancer. Theranostics 2021; 11:9054-9088. [PMID: 34522227 PMCID: PMC8419035 DOI: 10.7150/thno.62479] [Citation(s) in RCA: 58] [Impact Index Per Article: 19.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2021] [Accepted: 07/27/2021] [Indexed: 12/20/2022] Open
Abstract
In recent years tremendous effort has been invested in the field of cancer diagnosis and treatment with an overall goal of improving cancer management, therapeutic outcome, patient survival, and quality of life. Photodynamic Therapy (PDT), which works on the principle of light-induced activation of photosensitizers (PS) leading to Reactive Oxygen Species (ROS) mediated cancer cell killing has received increased attention as a promising alternative to overcome several limitations of conventional cancer therapies. Compared to conventional therapies, PDT offers the advantages of selectivity, minimal invasiveness, localized treatment, and spatio-temporal control which minimizes the overall therapeutic side effects and can be repeated as needed without interfering with other treatments and inducing treatment resistance. Overall PDT efficacy requires proper planning of various parameters like localization and concentration of PS at the tumor site, light dose, oxygen concentration and heterogeneity of the tumor microenvironment, which can be achieved with advanced imaging techniques. Consequently, there has been tremendous interest in the rationale design of PS formulations to exploit their theranostic potential to unleash the imperative contribution of medical imaging in the context of successful PDT outcomes. Further, recent advances in PS formulations as activatable phototheranostic agents have shown promising potential for finely controlled imaging-guided PDT due to their propensity to specifically turning on diagnostic signals simultaneously with photodynamic effects in response to the tumor-specific stimuli. In this review, we have summarized the recent progress in the development of PS-based multifunctional theranostic agents for biomedical applications in multimodal imaging combined with PDT. We also present the role of different imaging modalities; magnetic resonance, optical, nuclear, acoustic, and photoacoustic in improving the pre-and post-PDT effects. We anticipate that the information presented in this review will encourage future development and design of PSs for improved image-guided PDT for cancer treatment.
Collapse
Affiliation(s)
| | - Blassan P. George
- Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Doornfontein, South Africa
| | | |
Collapse
|
10
|
Krasnopeeva EL, Melenevskaya EY, Klapshina LG, Shilyagina NY, Balalaeva IV, Smirnov NN, Smirnov MA, Yakimansky AV. Poly(methacrylic Acid)-Cellulose Brushes as Anticancer Porphyrazine Carrier. NANOMATERIALS 2021; 11:nano11081997. [PMID: 34443825 PMCID: PMC8401802 DOI: 10.3390/nano11081997] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/09/2021] [Revised: 07/29/2021] [Accepted: 07/30/2021] [Indexed: 11/16/2022]
Abstract
The prospective strategy for treatment of cancer is based on the application of nano-sized macromolecular carriers, which are able penetrate inside and can be accumulated within tumor tissue. In this work graft copolymers of cellulose and poly(methacrylic acid) has been prepared and tested as a nanocontainers for the delivery of drug to tumor. For this purpose, two derivatives of porphyrazine suitable for photodynamic cancer therapy were loaded into prepared polymer brush. Fluorescence imaging was applied for monitoring of accumulation of porphyrazine in the CT26 murine colon carcinoma. The selective accumulation of cellulose brush loaded with porphyrazine in tumor was demonstrated by fluorescence intensity contrast between the tumor area and normal tissues. The tumor growth rate after photodynamic therapy were assessed and inhibition of its growth was revealed.
Collapse
Affiliation(s)
- Elena L. Krasnopeeva
- Institute of Macromolecular Compounds, Russian Academy of Sciences, 199004 Saint Petersburg, Russia; (E.L.K.); (E.Y.M.); (N.N.S.); (M.A.S.)
| | - Elena Yu. Melenevskaya
- Institute of Macromolecular Compounds, Russian Academy of Sciences, 199004 Saint Petersburg, Russia; (E.L.K.); (E.Y.M.); (N.N.S.); (M.A.S.)
| | - Larisa G. Klapshina
- Razuvaev Institute of Organomettalic Chemistry, Russian Academy of Sciences, 603137 Nizhniy Novgorod, Russia;
| | - Natalia Yu. Shilyagina
- Institute of Biology and Biomedicine, Nizhniy Novgorod State University, 603950 Nizhniy Novgorod, Russia; (N.Y.S.); (I.V.B.)
| | - Irina V. Balalaeva
- Institute of Biology and Biomedicine, Nizhniy Novgorod State University, 603950 Nizhniy Novgorod, Russia; (N.Y.S.); (I.V.B.)
| | - Nikolay N. Smirnov
- Institute of Macromolecular Compounds, Russian Academy of Sciences, 199004 Saint Petersburg, Russia; (E.L.K.); (E.Y.M.); (N.N.S.); (M.A.S.)
| | - Michael A. Smirnov
- Institute of Macromolecular Compounds, Russian Academy of Sciences, 199004 Saint Petersburg, Russia; (E.L.K.); (E.Y.M.); (N.N.S.); (M.A.S.)
| | - Alexander V. Yakimansky
- Institute of Macromolecular Compounds, Russian Academy of Sciences, 199004 Saint Petersburg, Russia; (E.L.K.); (E.Y.M.); (N.N.S.); (M.A.S.)
- Institute of Chemistry, Saint Petersburg State University, 198504 Saint Petersburg, Russia
- Correspondence:
| |
Collapse
|
11
|
Ray A, Bhattacharya S, Banerjee S. Photophysical insights on quantum dots-zinc porphyrazine system studied in solution. J INDIAN CHEM SOC 2021. [DOI: 10.1016/j.jics.2021.100068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
12
|
Koczorowski T, Szczolko W, Teubert A, Goslinski T. Sulfanyl Porphyrazines with Morpholinylethyl Periphery-Synthesis, Electrochemistry, and Photocatalytic Studies after Deposition on Titanium(IV) Oxide P25 Nanoparticles. Molecules 2021; 26:molecules26082280. [PMID: 33920778 PMCID: PMC8071117 DOI: 10.3390/molecules26082280] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Revised: 04/11/2021] [Accepted: 04/13/2021] [Indexed: 11/26/2022] Open
Abstract
The syntheses, spectral UV–Vis, NMR, and electrochemical as well as photocatalytic properties of novel magnesium(II) and zinc(II) symmetrical sulfanyl porphyrazines with 2-(morpholin-4-yl)ethylsulfanyl peripheral substituents are presented. Both porphyrazine derivatives were synthesized in cyclotetramerization reactions and subsequently embedded on the surface of commercially available P25 titanium(IV) oxide nanoparticles. The obtained macrocyclic compounds were broadly characterized by ESI MS spectrometry, 1D and 2D NMR techniques, UV–Vis spectroscopy, and subjected to electrochemical studies. Both hybrid materials, consisting of porphyrazine derivatives embedded on the titanium(IV) oxide nanoparticles’ surface, were characterized in terms of particle size and distribution. Next, they were subjected to photocatalytic studies with 1,3-diphenylisobenzofuran, a known singlet oxygen quencher. The applicability of the obtained hybrid material consisting of titanium(IV) oxide P25 nanoparticles and magnesium(II) porphyrazine derivative was assessed in photocatalytic studies with selected active pharmaceutical ingredients, such as diclofenac sodium salt and ibuprofen.
Collapse
Affiliation(s)
- Tomasz Koczorowski
- Chair and Department of Chemical Technology of Drugs, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland; (W.S.); (T.G.)
- Correspondence:
| | - Wojciech Szczolko
- Chair and Department of Chemical Technology of Drugs, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland; (W.S.); (T.G.)
| | - Anna Teubert
- Institute of Bioorganic Chemistry, Polish Academy of Sciences, Z. Noskowskiego 12, 61-704 Poznan, Poland;
| | - Tomasz Goslinski
- Chair and Department of Chemical Technology of Drugs, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland; (W.S.); (T.G.)
| |
Collapse
|
13
|
Robertson AG, Rendina LM. Gadolinium theranostics for the diagnosis and treatment of cancer. Chem Soc Rev 2021; 50:4231-4244. [DOI: 10.1039/d0cs01075h] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Combining therapeutic and diagnostic tools into a single ‘theranostic’ platform lies at the forefront of cancer research. Some of the most promising theranostics exploit the unique nuclear and electronic properties of the lanthanoid metal gadolinium.
Collapse
Affiliation(s)
| | - Louis M. Rendina
- School of Chemistry
- The University of Sydney
- Sydney
- Australia
- The University of Sydney
| |
Collapse
|
14
|
Synthesis of sulfanyl porphyrazines with bulky peripheral substituents – Evaluation of their photochemical properties and biological activity. J Photochem Photobiol A Chem 2021. [DOI: 10.1016/j.jphotochem.2020.112964] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
15
|
Abad Galán L, Hamon N, Nguyen C, Molnár E, Kiss J, Mendy J, Hadj-Kaddour K, Onofre M, Trencsényi G, Monnereau C, Beyler M, Tircsó G, Gary-Bobo M, Maury O, Tripier R. Design of polyazamacrocyclic Gd3+ theranostic agents combining magnetic resonance imaging and two-photon photodynamic therapy. Inorg Chem Front 2021. [DOI: 10.1039/d0qi01519a] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
New “all-in-one” theranostic systems, combining a magnetic resonance imaging contrast agent with a biphotonic photodynamic therapy photosensitiser generating cytotoxic singlet oxygen, were successfully developed and characterized.
Collapse
|
16
|
Simões JCS, Sarpaki S, Papadimitroulas P, Therrien B, Loudos G. Conjugated Photosensitizers for Imaging and PDT in Cancer Research. J Med Chem 2020; 63:14119-14150. [PMID: 32990442 DOI: 10.1021/acs.jmedchem.0c00047] [Citation(s) in RCA: 59] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Early cancer detection and perfect understanding of the disease are imperative toward efficient treatments. It is straightforward that, for choosing a specific cancer treatment methodology, diagnostic agents undertake a critical role. Imaging is an extremely intriguing tool since it assumes a follow up to treatments to survey the accomplishment of the treatment and to recognize any conceivable repeating injuries. It also permits analysis of the disease, as well as to pursue treatment and monitor the possible changes that happen on the tumor. Likewise, it allows screening the adequacy of treatment and visualizing the state of the tumor. Additionally, when the treatment is finished, observing the patient is imperative to evaluate the treatment methodology and adjust the treatment if necessary. The goal of this review is to present an overview of conjugated photosensitizers for imaging and therapy.
Collapse
Affiliation(s)
- João C S Simões
- Institute of Chemistry, University of Neuchatel, Avenue de Bellevaux 51, CH-2000 Neuchatel, Switzerland.,BioEmission Technology Solutions, Alexandras Avenue 116, 11472 Athens, Greece
| | - Sophia Sarpaki
- BioEmission Technology Solutions, Alexandras Avenue 116, 11472 Athens, Greece
| | | | - Bruno Therrien
- Institute of Chemistry, University of Neuchatel, Avenue de Bellevaux 51, CH-2000 Neuchatel, Switzerland
| | - George Loudos
- BioEmission Technology Solutions, Alexandras Avenue 116, 11472 Athens, Greece
| |
Collapse
|
17
|
Jenni S, Bolze F, Bonnet CS, Pallier A, Sour A, Tóth É, Ventura B, Heitz V. Synthesis and In Vitro Studies of a Gd(DOTA)-Porphyrin Conjugate for Combined MRI and Photodynamic Treatment. Inorg Chem 2020; 59:14389-14398. [PMID: 32960580 DOI: 10.1021/acs.inorgchem.0c02189] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
With the aim of developing new molecular theranostic agents, a π-extended Zn(II) porphyrin as photosensitizer for photodynamic therapy (PDT) linked to two GdDOTA-type complexes for magnetic resonance imaging (MRI) detection was synthesized. The relaxivity studies revealed a much higher relaxivity value per Gd ion for this medium sized molecule (19.32 mM-1 s-1 at 20 MHz and 298 K) compared to clinical contrast agents-a value which strongly increases in the presence of bovine serum albumin, reaching 25.22 mM-1 s-1. Moreover, the photophysical studies showed the strong ability of the molecule to absorb light in the deep red (670 nm, ε ≈ 60000 M-1 cm-1) and in the near-infrared following two-photon excitation (920 nm, σ2 ≈ 650 GM). The conjugate is also able to generate singlet oxygen, with a quantum yield of 0.58 in DMSO. Promising results were obtained in cellular studies, demonstrating that the conjugate is internalized in HeLa cells at micromolar concentration and leads to 70% of cell death following 30 min irradiation at 660 nm. These results confirm the potential of the designed molecule as an imaging and therapeutic agent.
Collapse
Affiliation(s)
- Sébastien Jenni
- Laboratoire de Synthèse des Assemblages Moléculaires Multifonctionnels, Institut de Chimie de Strasbourg, CNRS/UMR 7177, Université de Strasbourg, 4 rue Blaise Pascal, 67000 Strasbourg, France
| | - Frédéric Bolze
- CAMB, UMR 7199, Unistra/CNRS, Faculté de Pharmacie, Université de Strasbourg, 74 route du Rhin, 67401 Illkirch, France
| | - Célia S Bonnet
- Centre de Biophysique Moléculaire, CNRS UPR 4301, Université d'Orléans, rue Charles Sadron, CS 80054, 45071 Cedex 2 Orléans, France
| | - Agnès Pallier
- Centre de Biophysique Moléculaire, CNRS UPR 4301, Université d'Orléans, rue Charles Sadron, CS 80054, 45071 Cedex 2 Orléans, France
| | - Angélique Sour
- Laboratoire de Synthèse des Assemblages Moléculaires Multifonctionnels, Institut de Chimie de Strasbourg, CNRS/UMR 7177, Université de Strasbourg, 4 rue Blaise Pascal, 67000 Strasbourg, France
| | - Éva Tóth
- Centre de Biophysique Moléculaire, CNRS UPR 4301, Université d'Orléans, rue Charles Sadron, CS 80054, 45071 Cedex 2 Orléans, France
| | | | - Valérie Heitz
- Laboratoire de Synthèse des Assemblages Moléculaires Multifonctionnels, Institut de Chimie de Strasbourg, CNRS/UMR 7177, Université de Strasbourg, 4 rue Blaise Pascal, 67000 Strasbourg, France
| |
Collapse
|
18
|
Li H, Zeng Y, Zhang H, Gu Z, Gong Q, Luo K. Functional gadolinium-based nanoscale systems for cancer theranostics. J Control Release 2020; 329:482-512. [PMID: 32898594 DOI: 10.1016/j.jconrel.2020.08.064] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Revised: 08/25/2020] [Accepted: 08/30/2020] [Indexed: 02/07/2023]
Abstract
Cancer theranostics is a new strategy for combating cancer that integrates cancer imaging and treatment through theranostic agents to provide an efficient and safe way to improve cancer prognosis. Design and synthesis of these cancer theranostic agents are crucial since these agents are required to be biocompatible, tumor-specific, imaging distinguishable and therapeutically efficacious. In this regard, several types of gadolinium (Gd)-based nanomaterials have been introduced to combine different therapeutic agents with Gd to enhance the efficacy of therapeutic agents. At the same time, the entire treatment procedure could be monitored via imaging tools due to incorporation of Gd ions, Gd chelates and Gd/other imaging probes in the theranostic agents. This review aims to overview recent advances in the Gd-based nanomaterials for cancer theranostics and perspectives for Gd nanomaterial-based cancer theranostics are provided.
Collapse
Affiliation(s)
- Haonan Li
- Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and Molecular Imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Yujun Zeng
- Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and Molecular Imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Hu Zhang
- Amgen Bioprocessing Centre, Keck Graduate Institute, Claremont, CA 91711, USA
| | - Zhongwei Gu
- Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and Molecular Imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Qiyong Gong
- Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and Molecular Imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Kui Luo
- Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and Molecular Imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
| |
Collapse
|
19
|
Lermontova SA, Lyubova TS, Ladilina EY, Plekhanov VI, Balalaeva IV, Boyarskii VP, Klapshina LG. New Cyanoarylporphyrazines with High Sensitivity of Photophysical Parameters to Viscosity as Promising Agents for Photodynamic Therapy. RUSS J GEN CHEM+ 2020. [DOI: 10.1134/s1070363220020140] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
20
|
Biegger P, Ladd ME, Komljenovic D. Multifunctional Magnetic Resonance Imaging Probes. Recent Results Cancer Res 2020; 216:189-226. [PMID: 32594388 DOI: 10.1007/978-3-030-42618-7_6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Magnetic resonance imaging is characterized by high spatial resolution and unsurpassed soft tissue discrimination. Development and characterization of both intrinsic and extrinsic magnetic resonance (MR) imaging probes in the last decade has further strengthened the pivotal role MR imaging holds in the assessment of cancer in preclinical and translational settings. Sophisticated chemical modifications of a variety of nanoparticulate probes hold the potential to deliver valuable multifunctional tools applicable in diagnostics and/or treatment in human oncology. MR imaging suffers from a lack of sensitivity achievable by, e.g., nuclear medicine imaging methods. Advantages of including additional functionality/functionalities in a probe suitable for MR imaging are thus numerous, comprising the addition of fundamentally different imaging information (diagnostics), drug delivery (therapy), or the combination of both (theranostics). In recent years, we have witnessed a plethora of preclinical multimodal or multifunctional imaging probes being published mainly as proof-of-principle studies, yet only a handful are readily applicable in clinical settings. This chapter summarizes recent innovations in the development of multifunctional MR imaging probes and discusses the suitability of these probes for clinical transfer.
Collapse
Affiliation(s)
- Philipp Biegger
- Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Mark E Ladd
- Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.,Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.,Faculty of Physics and Astronomy, University of Heidelberg, Heidelberg, Germany
| | - Dorde Komljenovic
- Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
| |
Collapse
|
21
|
Mishchenko TA, Turubanova VD, Mitroshina EV, Alzeibak R, Peskova NN, Lermontova SA, Klapshina LG, Balalaeva IV, Vedunova MV, Krysko DV. Effect of novel porphyrazine photosensitizers on normal and tumor brain cells. JOURNAL OF BIOPHOTONICS 2020; 13:e201960077. [PMID: 31595675 DOI: 10.1002/jbio.201960077] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/13/2019] [Revised: 09/17/2019] [Accepted: 09/20/2019] [Indexed: 06/10/2023]
Abstract
Photodynamic therapy (PDT) is a clinically approved procedure for targeting tumor cells. Though several different photosensitizers have been developed, there is still much demand for novel photosensitizers with improved properties. In this study we aim to characterize the accumulation, localization and dark cytotoxicity of the novel photosensitizers developed in-house derivatives of porphyrazines (pz I-IV) in primary murine neuronal cells, as well as to identify the concentrations at which pz still effectively induces death in glioma cells yet is nontoxic to nontransformed cells. The study shows that incubation of primary neuronal and glioma cells with pz I-IV leads to their accumulation in both types of cells, but their rates of internalization, subcellular localization and dark toxicity differ significantly. Pz II was the most promising photosensitizer. It efficiently killed glioma cells while remaining nontoxic to primary neuronal cells. This opens up the possibility of evaluating pz II for experimental PDT for glioma.
Collapse
Affiliation(s)
- Tatiana A Mishchenko
- Institute of Biology and Biomedicine, Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russian Federation
| | - Victoria D Turubanova
- Institute of Biology and Biomedicine, Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russian Federation
| | - Elena V Mitroshina
- Institute of Biology and Biomedicine, Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russian Federation
| | - Razan Alzeibak
- Institute of Biology and Biomedicine, Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russian Federation
| | - Nina N Peskova
- Institute of Biology and Biomedicine, Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russian Federation
| | - Svetlana A Lermontova
- G.A. Razuvaev Institute of Organometallic Chemistry of the Russian Academy of Sciences, Nizhny Novgorod, Russian Federation
| | - Larisa G Klapshina
- G.A. Razuvaev Institute of Organometallic Chemistry of the Russian Academy of Sciences, Nizhny Novgorod, Russian Federation
| | - Irina V Balalaeva
- Institute of Biology and Biomedicine, Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russian Federation
| | - Maria V Vedunova
- Institute of Biology and Biomedicine, Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russian Federation
| | - Dmitri V Krysko
- Institute of Biology and Biomedicine, Lobachevsky State University of Nizhni Novgorod, Nizhny Novgorod, Russian Federation
- Cell Death Investigation and Therapy (CDIT) Laboratory, Department of Human Structure and Repair, Ghent University, Ghent, Belgium
- Cancer Research Institute Ghent, Ghent, Belgium
| |
Collapse
|
22
|
Abstract
Theranostic approaches using nanotechnology have been a hot research area for the past decade. All nano drug delivery techniques and architectures have some limitations, as do diagnostic nano-approaches. Thus, combining nano drug delivery strategies with diagnostic techniques using nanoparticles for improving imaging modalities has been the key to fill up those gaps. In the past decade, lots of approaches have been made with different combinations of biomaterials fabricated/synthesized to nanostructures with modified surface functionalization to improve their overall theranostic properties. This article summarizes recent research works based on the biomaterials used for fabricating these nanostructures. Their combinations with other biomaterials have been demonstrated with their overall advantages and limitations.
Collapse
|
23
|
Manda G, Hinescu ME, Neagoe IV, Ferreira LF, Boscencu R, Vasos P, Basaga SH, Cuadrado A. Emerging Therapeutic Targets in Oncologic Photodynamic Therapy. Curr Pharm Des 2019; 24:5268-5295. [DOI: 10.2174/1381612825666190122163832] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2018] [Accepted: 01/18/2019] [Indexed: 12/20/2022]
Abstract
Background:Reactive oxygen species sustain tumorigenesis and cancer progression through deregulated redox signalling which also sensitizes cancer cells to therapy. Photodynamic therapy (PDT) is a promising anti-cancer therapy based on a provoked singlet oxygen burst, exhibiting a better toxicological profile than chemo- and radiotherapy. Important gaps in the knowledge on underlining molecular mechanisms impede on its translation towards clinical applications.Aims and Methods:The main objective of this review is to critically analyse the knowledge lately gained on therapeutic targets related to redox and inflammatory networks underlining PDT and its outcome in terms of cell death and resistance to therapy. Emerging therapeutic targets and pharmaceutical tools will be documented based on the identified molecular background of PDT.Results:Cellular responses and molecular networks in cancer cells exposed to the PDT-triggered singlet oxygen burst and the associated stresses are analysed using a systems medicine approach, addressing both cell death and repair mechanisms. In the context of immunogenic cell death, therapeutic tools for boosting anti-tumor immunity will be outlined. Finally, the transcription factor NRF2, which is a major coordinator of cytoprotective responses, is presented as a promising pharmacologic target for developing co-therapies designed to increase PDT efficacy.Conclusion:There is an urgent need to perform in-depth molecular investigations in the field of PDT and to correlate them with clinical data through a systems medicine approach for highlighting the complex biological signature of PDT. This will definitely guide translation of PDT to clinic and the development of new therapeutic strategies aimed at improving PDT.
Collapse
Affiliation(s)
| | | | | | - Luis F.V. Ferreira
- CQFM-Centro de Fisica Molecular and IN-Institute for Nanosciences and Nanotechnologies and IBB-Institute for Bioengineering and Biosciences, Instituto Superior Tecnico, Universidade de Lisboa, Lisbon, Portugal
| | | | - Paul Vasos
- Research Centre of the University of Bucharest, Bucharest, Romania
| | - Selma H. Basaga
- Molecular Biology Genetics & Program, Faculty of Engineering & Natural Sciences, Sabanci University, Istanbul, Turkey
| | | |
Collapse
|
24
|
Molecular Theranostic Agents for Photodynamic Therapy (PDT) and Magnetic Resonance Imaging (MRI). INORGANICS 2019. [DOI: 10.3390/inorganics7010010] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Magnetic resonance imaging (MRI) is a powerful non-invasive diagnostic tool that can provide important insights for medical treatment monitoring and optimization. Photodynamic therapy (PDT), a minimally invasive treatment for various types of tumors, is drawing increasing interest thanks to its temporal and spatial selectivity. The combination of MRI and PDT offers real-time monitoring of treatment and can give significant information for drug-uptake and light-delivery parameters optimization. In this review we will give an overview of molecular theranostic agents that have been designed for their potential application in MRI and PDT.
Collapse
|
25
|
Schmitt J, Jenni S, Sour A, Heitz V, Bolze F, Pallier A, Bonnet CS, Tóth É, Ventura B. A Porphyrin Dimer–GdDOTA Conjugate as a Theranostic Agent for One- and Two-Photon Photodynamic Therapy and MRI. Bioconjug Chem 2018; 29:3726-3738. [DOI: 10.1021/acs.bioconjchem.8b00634] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Julie Schmitt
- Laboratoire de Synthèse des Assemblages Moléculaires Multifonctionnels, Institut de Chimie de Strasbourg, CNRS/UMR 7177, Université de Strasbourg, 4, rue Blaise Pascal, 67000 Strasbourg, France
| | - Sébastien Jenni
- Laboratoire de Synthèse des Assemblages Moléculaires Multifonctionnels, Institut de Chimie de Strasbourg, CNRS/UMR 7177, Université de Strasbourg, 4, rue Blaise Pascal, 67000 Strasbourg, France
| | - Angélique Sour
- Laboratoire de Synthèse des Assemblages Moléculaires Multifonctionnels, Institut de Chimie de Strasbourg, CNRS/UMR 7177, Université de Strasbourg, 4, rue Blaise Pascal, 67000 Strasbourg, France
| | - Valérie Heitz
- Laboratoire de Synthèse des Assemblages Moléculaires Multifonctionnels, Institut de Chimie de Strasbourg, CNRS/UMR 7177, Université de Strasbourg, 4, rue Blaise Pascal, 67000 Strasbourg, France
| | - Frédéric Bolze
- CAMB, CNRS/UMR 7199, Faculté de Pharmacie, Université de Strasbourg, 74 route du Rhin, 67401 Illkirch, France
| | - Agnès Pallier
- Centre de Biophysique Moléculaire UPR4301, CNRS, Université d’Orléans, rue Charles Sadron, 45071 Orléans, France
| | - Célia S. Bonnet
- Centre de Biophysique Moléculaire UPR4301, CNRS, Université d’Orléans, rue Charles Sadron, 45071 Orléans, France
| | - Éva Tóth
- Centre de Biophysique Moléculaire UPR4301, CNRS, Université d’Orléans, rue Charles Sadron, 45071 Orléans, France
| | | |
Collapse
|
26
|
Lermontova SA, Grigor’ev IS, Ladilina EY, Balalaeva IV, Shilyagina NY, Klapshina LG. Porphyrazine Structures with Electron-Withdrawing Substituents as the Base for Materials for Photonics and Biomedicine. RUSS J COORD CHEM+ 2018. [DOI: 10.1134/s1070328418040061] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|